AzTrials
AzTrials

Calcium MetabolismNCT00393289

Calcium Absorption and Retention From Marine Products

A study of Calcium Metabolism, run by University of Copenhagen at 1 site in Denmark.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The purpose of the study is to determine the uptake of calcium from fish bone meal from salmon and cod in 12 healthy volunteers. A test meal labelled with trace amounts of a radioactive calcium isotope (Ca47) will be given after an overnight fast and whole body retention of calcium will be measured on day 13, 21, and… Read more about this study

Who is it for?
Ages 18 to 40 years, men onlyHealthy volunteers can take part
Conditions the study is for
Calcium Metabolism
How many people
12 participants
Where
1 siteDenmark
Study dates
Nov 2005to Mar 2007
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 40 years
  • Men only
  • Healthy volunteers accepted
  • Adult

Who may be able to join

  • healthy males
  • BMI: 18-18 kg/m2
  • age: 18-40 years

Who cannot join

  • elite athletes
  • on medication
  • gastrointestinal disorders, chronic diseaes
  • smoking
  • prior participation in radioisotpe studies

Trial locations and contacts

1 site in 1 country.

Denmark1 site
  • Institute of Human Nutirtion, The Royal Veterinary and Agricultural University, Denmark

    Frederiksberg, Frederiksberg C, 1958

Other trials in Denmark

About this study

The purpose of the study is to determine the uptake of calcium from fish bone meal from salmon and cod in 12 healthy volunteers. A test meal labelled with trace amounts of a radioactive calcium isotope (Ca47) will be given after an overnight fast and whole body retention of calcium will be measured on day 13, 21, and 24 after the test meal day.

Read the detailed description

Background:

Up till now little attention has been given the exploitation of marine by-products from the fishing industry. Calcium in fish is found mainly in bone and skin. By-products from these sources are limited to production of gelatine. Small fish, which can be eaten whole with bones included, are traditionally considered to be a good source of calcium. Until recently, bioavailability of this calcium was not known. Two recent studies from Denmark have shown that the absorption of calcium from small soft-boned fish was comparable to that of skimmed milk both in rats and in humans.

Calcium fortified foods are likely to play an important role in helping consumers to achieve calcium requirements aimed at reducing the risk of developing osteoporosis. Experimental evidence show a positive effect of calcium supplementation on bone mineral accretion in children, and combined calcium and vitamin D supplementation has resulted in reduced bone loss and fracture incidence in older men and women.

This protocol describes a project on the nutritional utilisation of calcium from fish bone waste. The main objective is to maximise the use and the added value of marine by-products with special emphasis on utilisation of fish bone as a calcium source and determine its bioavailabiliy in humans.

Study design :

This study will follow a 3x7 weeks ransomised crossover design, where the calcium absorption and retention will be measured form meals labelled with 47Ca. The test meals will be digested in the morning after a 12h fast and bloodsampling. Whole body retention will be measured on day 15, 22 and 26, and calibrated against a background measurement from the day prior to ingestion of the test meal. The subjects will receive an ordinary standardised diet for 2 days prior and 3 days after the test meals. This diet will be standardised to match the subjects' individual calcium intake.

Test meals:

Two types of fish bone meal (from salmon and cod fish) and a control (CaCO3) will be tested. Amounts equivalent of 800 mg Ca will be baked into bread, which will be labelled with 47Ca and served with 500 mL of ultra pure water at the department.

Isotopes and labelling procedure:

Isotopes (47Ca) will be ordered from Risø National Laboratory, Radiation Research Department, Denmark. The department of Human Nutrition will recieve the prepared doses of isotopes the day before the test meal. A dose of 0.2 MBq/ml will be used. The doses will be used to extrinsically label the test meals by drop-wise adding 1 ml of isotope solution in the afternoon on the day before intake of test meals and stored at 5 degree C until ingested.

Since each subject will recieve labelled meals on three occasions, a total dose of 0.6 MBq will be ingested during the study.

Measurement of calcium retention:

The whole body retention of calcium will be measured with a whole body counter at the Copenhagen University Hospital, Denmark. All measurements of calcium retention will be corrected for physical decay back to the time of administration.

Chemical analyses:

Serun calcium, phosphorus and vitamin D concentrations will be determined in before each test meal. Plasma levels of PTH will be determined before the first test meal only.

Being tested
Calcium controlled diet
Keywords
Calcium absorption, D-vitamin status, Whole body calcium retention, Calcium intake, PTH status

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Calcium controlled dietBehavioural

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Whole body retention of calcium

Secondary outcomes (1)
  1. D-vitamin and PTH status, serum calcium and phosporus, and calcium intake

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted27 Oct 2006 (estimated)
  2. Study startNov 2005
  3. Primary completionApr 2006
  4. Study completionMar 2007

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Basic science
Allocation
Randomised
Intervention model
Crossover
Masking
Quadruple blind
Who is masked
Participant, Care provider, Investigator, Outcomes assessor
Enrolment
12 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT00393289
Sponsor's protocol ID
KF-01270319
Other IDs
M182
Status last verified
Jul 2016
First submitted
26 Oct 2006
Last updated
20 Jul 2016
Results posted
No
Data monitoring committee
No
Individual data sharing
Yes

Questions about this trial

What is this clinical trial studying?

A study of Calcium Metabolism, run by University of Copenhagen at 1 site in Denmark.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 5 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 20 Jul 2016. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Denmark. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Whole body retention of calcium. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 20 Jul 2016.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in